Maximally safe resection followed by hypofractionated re‐irradiation for locally recurrent ependymoma in children
- 3 March 2009
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 52 (7), 804-807
- https://doi.org/10.1002/pbc.21982
Abstract
Background Treatment failure in children with ependymoma is relatively common, with the majority of events consisting of local failure. Salvage therapy for these children historically had poor results, with repeated local recurrences. To improve these outcomes, we began to offer hypofractionated re-irradiation after resection at first local recurrence. To minimize the duration of therapy, we chose a hypofractionated regimen that has been shown to be well tolerated in adult patients. Procedure We performed a review of the experience at the Children's Hospital in Denver and at the Department of Radiation Oncology at the University of Colorado Denver from 1995 to 2008 with hypofractionated re-irradiation after maximally safe resection in children with locally recurrent ependymoma. Results Six children with locally recurrent ependymoma were seen in that time period. After maximally safe resection, all six received hypofractionated radiation therapy of 24–30 Gy delivered in three fractions. With a median follow-up of 28 months from the time of re-irradiation, all six children are alive with no evidence of disease. Three children had evidence of radiation necrosis, either clinically or based on imaging, but none required significant intervention. Conclusions Hypofractionated re-irradiation after resection for locally recurrent ependymoma is well tolerated. This approach also appears to provide good local control. Additional follow-up is required to determine the efficacy and potential late effects of hypofractionated re-irradiation in this patient population. Pediatr Blood Cancer 2009;52:804–807.Keywords
This publication has 26 references indexed in Scilit:
- A Retrospective Study of Surgery and Reirradiation for Recurrent EpendymomaInternational Journal of Radiation Oncology*Biology*Physics, 2008
- A Phase I Dose-Escalation Study of Fractionated Stereotactic Radiosurgery in Combination With Gefitinib in Patients With Recurrent Malignant GliomasInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Preliminary Results From a Phase II Trial of Conformal Radiation Therapy and Evaluation of Radiation-Related CNS Effects for Pediatric Patients With Localized EpendymomaJournal of Clinical Oncology, 2004
- Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: The Duke experienceNeuro-Oncology, 2002
- A Multi-Institutional Retrospective Study of Intracranial Ependymoma in ChildrenJournal of Pediatric Hematology/Oncology, 1999
- Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer GroupJournal of Neurosurgery, 1998
- Intracranial Ependymomas: Analysis of Prognostic Factors in a Population-Based SeriesPediatric Neurosurgery, 1996
- A High-Dose Busulfan-Thiotepa Combination Followed by Autologous Bone Marrow Transplantation in Childhood Recurrent EpendymomaPediatric Neurosurgery, 1996
- Intracranial Ependymomas of ChildhoodNeurosurgery, 1995
- Treatment of intracranial ependymomas of children: review of a 15-year experienceInternational Journal of Radiation Oncology*Biology*Physics, 1994